NCT07473037尚未招募不适用
Evaluation of the Efficacy of an in and Out Collagen Routine Versus the Serum Alone and Versus the Oral Supplement Alone in Women With Skin Ageing Signs
Vichy Laboratoires0 个研究点目标入组 165 人开始时间: 2026年3月15日最近更新:
干预措施
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 165
- 主要终点
- Crow's feet score on the L'Oreal Skin Atlas (Caucasian type) scale ranging from 0=no wrinkles to 6=very deep severe wrinkles
研究概览
简要总结
This clinical study is conducted at one study site and in 165 women with visible signs of skin aging. It compares after 13 weeks the benefit of a combined oral collagen supplement and topical collagen serum regimen compared with oral collagen alone and topical collagen serum alone in reducing in women presenting visible signs of skin ageing .
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Single (Investigator)
盲法说明
products will be investigator masked
入排标准
- 年龄范围
- 45 Years 至 60 Years（Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •Participant having signed an Informed Consent Form (ICF) before any trial related activity is carried out;
- •Female participant;
- •Participant with a Fitzpatrick skin type I to III;
- •Participant aged 45 to 60 years inclusive at the time of signing the ICF;
- •Participant with a BMI ≥20 and < 29 kg/m²;
- •Participant presenting:
- •Cheek firmness score ≥3 and ≤6 on the 10-point scale;
- •Crow's feet wrinkle score ≥2 and ≤4 on the L'Oréal Atlas;
- •Global facial wrinkle score ≥3 and ≤6 on the 10-point scale.
- •Female participant of childbearing potential must use one of the reliable methods of contraception during the investigation and agree not to change it during the study;
- •A woman is considered of childbearing potential unless she is:
- •Postmenopausal for at least 12 months prior to screening visit;
- •Without uterus and/or both ovaries;
- •Has been surgically sterile for at least 6 months prior to Screening visit.
- •Participant must agree to use only the designated products
- •Participant willing and able to comply with all study procedures, lifestyle and dietary restrictions, and complete the entire study period
- •Participant affiliated to a health social security system (according to French Law).
排除标准
- •Participant who is pregnant or who is breast feeding;
- •Participant receiving hormone replacement therapy (HRT).
- •Participant who smokes more than two cigarettes per week;
- •Participant whose alcohol intake exceeds 2 drinks per week;
- •Participant with any uncontrolled diseases such as diabetes, hypertension, hyperthyroidism or hypothyroidism;
- •Presenting or having a history of eating disorder (e.g. anorexia, food allergy) or gastro-intestinal malabsorption such as celiac disease, Crohn's disease, lactose intolerance;
- •Participant with an history of sleeve or bypass;
- •Participant with skin abnormalities (e.g., scars, excessive hair, tattooing) or any dermatosis (e.g., psoriasis, eczema, acne vulgaris) on the face which could interfere with the study;
- •Participant with history of any severe disease or current condition which, in the opinion of the Investigator would put the participant at risk by participating in the study or would interfere significantly with the evaluation of study results
- •Participant with known or suspected hypersensitivity to any ingredient(s) of the investigational products;
- •Participants having undergone any aesthetic procedures (such as chemical peels, laser treatments, dermabrasions, injections, anti-ageing masks, hair implants, etc.) on the test areas within 6 months prior to the start of the study are excluded.
- •Participant who, in the opinion of the investigator, is unlikely to comply with the Clinical Study Protocol (e.g., alcoholism, drug dependency or psychotic state);
- •Participant having use systemic corticosteroids, immunosuppressive drugs, or retinoids (oral or topical) within 3 months prior to study enrollment;
- •Only for participants (20 in each group) who are willing to accept skin microbiopsies: The participant who has a contraindication to skin biopsies
- •Participant impossible to contact in case of emergency;
- •Participant with current participation in any other interventional clinical study, based on interview of the Participant;
- •Participant who is in an exclusion period in the National Biomedical Research Register of the French Ministry of Health at randomization;
- •Participant who has been deprived of their freedom by administrative or legal decision, or who is under care of a guardian or legal guardianship, or Participant hospitalized in a medical or social establishment for any reason.
研究组 & 干预措施
Group 1: Combined oral collagen supplement + topical collagen serum
Experimental
combination of oral collagen supplementation and topical application of collagen serum
干预措施: Oral collagen (Dietary Supplement)
Group 1: Combined oral collagen supplement + topical collagen serum
Experimental
combination of oral collagen supplementation and topical application of collagen serum
干预措施: topical application of collagen serum (Other)
Group 2: Oral collagen supplement alone
Active Comparator
oral collagen supplementation
干预措施: Oral collagen (Dietary Supplement)
Group 3: Topical collagen serum alone
Active Comparator
topical application of collagen serum
干预措施: topical application of collagen serum (Other)
结局指标
主要结局
Crow's feet score on the L'Oreal Skin Atlas (Caucasian type) scale ranging from 0=no wrinkles to 6=very deep severe wrinkles
时间窗: Baseline, Week 3, Week 7, Week 13
次要结局
- Nasolabial fold score on the L'Oreal Skin Atlas (Caucasian type) scale ranging from 0=no fold to 5=very deep/severe fold(baseline, week 3, week 7, week 13)
- Upper lip wrinkle score on the L'Oreal Skin Atlas (Caucasian type) scale ranging from 0=no wrinkles to 6=very deep/severe wrinkles(baseline, week 3, week 7, week 13)
- Wrinkles of the corner of the lip score on the L'Oreal Skin Atlas (Caucasian type) scale ranging from 0=no wrinkles to 6=very deep/severe wrinkles(baseline, week 3, week 7, week 13)
- Ptosis of the lower part of the face on the L'Oreal Skin Atlas (Caucasian type) scale ranging from 0=no wrinkles to 5=very deep/severe fold(baseline, week 3, week 7, week 13)
- Forhead wrinkle score on the L'Oreal Skin Atlas (Caucasian type) scale ranging from 0=no wrinkles to 5=very deep/severe wrinkles(baseline, week 3, week 7, week 13)
- Glabellar's wrinkle score on the L'Oreal Skin Atlas (Caucasian type) scale ranging from 0=no wrinkles to 5=very deep/severe wrinkles(baseline, week 3, week 7, week 13)
- Underneath eye wrinkle score on the L'Oreal Skin Atlas (Caucasian type) scale ranging from 0=no wrinkles to 5=very deep/severe wrinkles(baseline, week 3, week 7, week 13)
- Whole face wrinkles on a scale from 0=no visible wrinkle to 9= very visible wrinkle (clinical visual evaluation by the investigator)(baseline, week 3, week 7, week 13)
- Skin firmness on a scale from 0=very firm skin to 9= very saggy/not firm skin (clinical tactile evaluation by the investigator)(baseline, week 3, week 7, week 13)
- Skin elasticity on a scale from 0=very elastic skin to 9= very loose/not elastic skin (clinical tactile evaluation by the investigator)(baseline, week 3, week 7, week 13)
- Skin tone eveness on a scale from 0=very even skin tone to 9= very even skin tone (clinical visual evaluation by the investigator)(baseline, week 3, week 7, week 13)
- Skin radiance on a scale from 0=very radiant complexion to 9= uneven complexion/ dull complexion (clinical visual evaluation by the investigator)(baseline, week 3, week 7, week 13)
- Skin smoothness on a scale from 0=very smooth skin texture, 9=very rough skin texture (clinical visual evaluation by the investigator)(baseline, week 3, week 7, week 13)
- Skin density on a scale from0 = very low density, 9 = very high density (clinical tactile evaluation by the investigator)(baseline, week 3, week 7, week 13)
- Assessment of the mechanical properties of the skin by measuring its elasticity, firmness, and viscoelasticity using a cutometer (units: penetration depth in mm/time)(baseline, week 3, week 7, week 13)
- Creating an imprint of a specific shape on the skin using a Dermotrac®. Its handle houses a spring-loaded piston that applies a consistent pressure of up to 2 kg on the skin.(baseline, week 3, week 7, week 13)
- Dermis density using SIAscope (Spectophotometric intracutaneous analysis; arbitrary units)(baseline, week 3, week 7, week 13)
- Image acquisition: LC-OCT Acquisition(baseline, week 3, week 7, week 13)
- Image acquisition: Selfies acquisition(baseline, week 3, week 7, week 13)
- Image acquisition: ColorFace Acquisitions(Baseline, week 3, week 7, week 13)
- Subject Self-Assessment Questionnaire(week 3, week 7 and week 13)
- Global Investigator satisfaction on a scale from 0= not satisfied to 5= very satisfied with the clinical outcome(week 13)
研究者
相似试验
尚未招募
不适用
A Study to Evaluate the Efficacy of Collagen 16 Serum Alone, Against and as an Adjunct to Radiesse® Biostimulation Procedure in Female Trial Participants With Aged SkinNCT07446361Vichy Laboratoires180
已完成
不适用
Evaluation of Hydrating Cream Effect on Subjects With Dry Skin.NCT07393191Lacer S.A.35
已完成
不适用
Multidimensional Correlation Study on Skin Aging in Menopausal WomenMenopauseNCT07390305ChinaNorm100
已完成
Unknown
Anti-Ageing Potential of Silphion Oral Collagen PowderCTRI/2025/02/081060Silphion Research Pvt Ltd50
尚未招募
不适用
Collagenic vs Collagen-enriched Graft in Sinus Elevation: RCTNCT07386184Studio Odontoiatrico Associato Dr. P. Cicchese e L. Canullo24